Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

NIH Workshop: Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain

Source: NIH Part of the NIH HEAL (Helping to End Addiction Long-Term) Initiative, this NIH workshop will be held November 14-15, 2018 in Washington DC. For more information .

Governor Cuomo Signs Bill Adding Pain Management to List of Eligible Conditions for Treatment with Medical Marijuana

Source: Governor Andrew M. Cuomo Governor Andrew M. Cuomo signed legislation (S8987A/A 11011-B) that adds acute pain management to the list of conditions for which medical marijuana can be recommended as an alternative to opioid use. The bill will also allow for substance use disorder treatment providers to recommend medical marijuana to help patie...
Continue reading

Immediate-Release Opioids Now Under REMS

Source: FDA The FDA has broadened its Risk Evaluation and Mitigation Strategy (REMS) to include immediate-release opioid analgesics as well as the extended-release, long-acting agents previously covered. AAPM has provided ongoing input to the FDA at each stage of this REMS development and was an active advocate for extending the program to include ...
Continue reading

Anti-Opioid Abuse Package Passes the Senate

Source: Committee on the Judiciary Last week, the U.S. Senate passed HR 6, a broad, anti-opioid abuse package comprised of 70 separate opioid-related bills. Full story . Read the Pain Care Coalition position on HR 6 .

Facing Addiction in America: The Surgeon General’s Spotlight on Opioids

Source: U.S. Department of Health and Human Services (HHS) This document assembles opioid-related information from Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health in one document and provides updated data on the prevalence of substance use, opioid misuse, opioid use disorders, opioid overdoses, and related ha...
Continue reading

CDC’s New Quality Improvement and Care Coordination Resource

Source: CDC CDC, in collaboration with clinicians in the field, developed and published the resource Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain as a framework for primary care providers, practices, and healthcare systems to manage patients on long-term opioid therapy. Full stor...
Continue reading

AAPM Statement on National Decline in Opioid Prescribing

A statement from the American Academy of Pain Medicine Data released by IQVIA, a health care consulting company that regularly gathers prescribing data from pharmacies across the country, documenting a 22-percent decrease in opioid prescriptions nationally between 2013 and 2017 clearly shows that prescribers have been more judicious in prescribing ...
Continue reading
Topics:

Surgeon General Public Health Advisory Urges More Americans to Carry the Opioid-Reversing Drug, Naloxone

A statement from the American Academy of Pain Medicine The American Academy of Pain Medicine (AAPM) applauds U.S. Surgeon General Jerome M. Adams, MD, MPH comments urging more Americans to carry naloxone, a lifesaving medication that can reverse the effects of an opioid overdose. In a public health advisory , the Surgeon General encouraged patients...
Continue reading
Topics:

AAPM Supports FDA in Development of Evidence-Based Opioid Prescribing Guidelines

A statement from the American Academy of Pain Medicine The American Academy of Pain Medicine (AAPM) welcomes FDA Commissioner Scott Gottlieb's comments suggesting the development of evidence-based opioid prescribing guidelines. We stand at the ready to participate in the development of these guidelines for common procedures that could then be incor...
Continue reading
Topics:

Response to Senator McCaskill Report

A statement from the American Academy of Pain Medicine As pain physicians, our primary commitment is to provide the best possible care and treatment to our patients. The Academy's policies prohibit our education and advocacy positions to be compromised by outside influences, such as pharmaceutical companies, just as newspapers and other media outle...
Continue reading